WAG
REGN icon

Wiser Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Wiser Advisor Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44
Closed -$27.9K – 207
2025
Q1 		$27.9K Hold
44
– – 0.04% 127
2024
Q4 		$31.3K Hold
44
– – 0.05% 117
2024
Q3 		$46.3K Hold
44
– – 0.07% 101
2024
Q2 		$46.2K Hold
44
– – 0.07% 99
2024
Q1 		$42.4K Hold
44
– – 0.07% 104
2023
Q4 		$38.6K Buy
+44
New +$36.2K 0.06% 108

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wiser Advisor Group's REGN Position: Q2 2025 in Review

Wiser Advisor Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 44 shares — an estimated $27.9K sold.

Wiser Advisor Group first reported a position in REGN in Q4 2023 and held it in 6 quarters. The position peaked at $46.3K in Q3 2024. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Wiser Advisor Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Wiser Advisor Group sold 44 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $27.9K.
  • Wiser Advisor Group first reported a position in Regeneron Pharmaceuticals in Q4 2023 and held it in 6 quarters.
  • Wiser Advisor Group's Regeneron Pharmaceuticals position peaked at $46.3K in Q3 2024.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Wiser Advisor Group's 13F filing for Q2 2025, filed 8 Aug 2025.